Skip to main content

Advertisement

SpringerLink
Log in

The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses

  • Original Paper
  • Published:
Endocrine Aims and scope Submit manuscript

An Erratum to this article was published on 09 December 2012

Abstract

Incidentally discovered adrenal masses are diagnosed with increasing frequency, especially among patients with hypertension. Thus, a reliable screening test for primary hyperaldosteronism (PA) is essential to avoid unnecessary diagnostic procedures to this population. The aim of the present study is the evaluation of aldosterone to renin ratio (ARR), using plasma renin concentration, in the diagnostic algorithm of patients with adrenal incidentaloma. A total of 123 individuals were studied: 17 patients with proven PA (age 55.5 ± 1.4 years), 27 patients with nonfunctioning adrenal incidentaloma (age 60.3 ± 1.8 years, 14 hypertensives and 13 normotensives) and 79 control subjects (age 58.7 ± 1.4 years, 27 hypertensives and 52 normotensives). A receiver operating characteristic (ROC) analysis disclosed that an ARR ≥32 combines a sensitivity of 100% with a specificity of 96.2% for the diagnosis of PA. No difference in ΑRR between hypertensive and normotensive individuals harbouring an adrenal incidentaloma and hypertensive and normotensive controls was found. Patients with adrenal incidentalomas with subtle glucocorticoid hypersecretion demonstrated similar ARR compared to patients with normal cortisol secretion. In conclusion, ARR is reliable for the exclusion of PA in patients with adrenal incidentalomas. Furthermore, subtle aldosterone hypersecretion, as indicated by increased ARR, in patients with adrenal incidentalomas is not associated with the presence of hypertension or subtle glucocorticoid hypersecretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. M.M. Grumbach, B.M. Biller, G.D. Braunstein, K.K. Campbell, J.A. Carney, P.A. Godley, E.L. Harris, J.K. Lee, Y.C. Oertel, M.C. Posner, J.A. Schlechte, H.S. Wieand, Management of the clinically inapparent adrenal mass (“incidentaloma”) [NIH Conference]. Ann. Inter. Med. 138, 424–429 (2003)

    Google Scholar 

  2. G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, S.R. Bornstein, The Clinically Inapparent Adrenal Mass: Update in Diagnosis and management. Endocr. Rev. 25, 309–340 (2004)

    Article  PubMed  Google Scholar 

  3. F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A.M. Masini, A. Ali, M. Giovagnetti, G. Opocher, A. Angeli, A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85, 637–644 (2000)

    Article  PubMed  CAS  Google Scholar 

  4. G. Bernini, A. Moretti, G. Argenio, A. Salvetti, Primary aldosteronism in normokalemic patients with adrenal incidentalomas. Eur. J. Endocrinol. 146, 523–529 (2002)

    Article  PubMed  CAS  Google Scholar 

  5. W.F. Young, (2007). The incidentally discovered adrenal mass. N. Engl. J. Med. 356, 601–610

    Article  PubMed  CAS  Google Scholar 

  6. S. Tsagarakis, C. Roboti, P. Kokkoris, V. Vasiliou, C. Alevizaki, N.C. Thalassinos, Elevated post dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clin. Endocrinol. 49, 165–171 (1998)

    Article  CAS  Google Scholar 

  7. N. Valli, B. Catargi, N. Ronci, V. Vergnot, F. Leccia, J.M. Ferriere, G. Chene, N. Grenier, F. Laurent, A. Tabarin, Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. Eur. J. Endocrinol. 144, 401–408 (2001)

    Article  PubMed  CAS  Google Scholar 

  8. W.F. Young, Primary hyperaldosteronism: renaissance of a syndrome. Clin. Endocrinol. 66, 607–618 (2007)

    Article  CAS  Google Scholar 

  9. K. Hiramatsu, T. Yamada, Y. Yukimura, I. Komiya, K. Ichikawa, M. Ishihara, H. Nagata, T. Izumiyama, A screening test to identify aldosterone producing adenoma by measuring plasma renin activity: results in hypertensive patients. Arch. Inter. Med. 141, 1589–1593 (1981)

    Article  CAS  Google Scholar 

  10. N.M. Kaplan, The current epidemic of primary aldosteronism: causes and consequences. J. Hypertens. 22, 863–869 (2004)

    Article  PubMed  CAS  Google Scholar 

  11. R.D. Gordon, The challenge of more robust and reproducible methodology in screening for primary aldosteronism. J. Hypertens. 22, 251–255 (2004)

    Article  PubMed  CAS  Google Scholar 

  12. J.K. Doig, K.S. Lees, J.L. Reid, The effect of drugs on the renin-angiotensin system in man. in The Renin-angiotensin System, eds. by J.I.S. Robertson, M.G. Nicholls (Merk, London, 1993), pp. 80.1–80.19

  13. T.J. McKenna, S.J. Sequeira, A. Heffernan, J. Chambers, S. Cunningham, Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J. Clin. Endocrinol. Metabol. 73, 952–957 (1991)

    Article  CAS  Google Scholar 

  14. A. Tanabe, M. Naruse, S. Takagi, K. Tsuchiya, T. Imaki, K. Takano, Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J. Clin. Endocrinol. Metabol. 88, 2489–2494 (2003)

    Article  CAS  Google Scholar 

  15. S.J. Duffy, E.S. Biegelsen, R.T. Eberhardt, D.F. Kahn, B.A. Kingwell, J.A. Vita, Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation. Hypertension 46, 707–713 (2005)

    Article  PubMed  CAS  Google Scholar 

  16. S.C. Tiu, C.H. Choi, C.C. Shek, Y.w. Ng, F.K.W. Chan, C.M. Ng, A.P. Kong, The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J. Clin. Endocrinol. Metabol. 90, 72–78 (2005)

    Article  CAS  Google Scholar 

  17. P.E. Plouin, P. Cudek, J.F. Arnal, T.T. Guyene, P. Corvol, Immunoradiometric assay of active renin versus determinations of plasma renin activity in the clinical investigation of hypertension, congestive heart failure, and liver cirrhosis. Horm. Res. 34, 138–141 (1990)

    Article  PubMed  CAS  Google Scholar 

  18. F.H. Derkx, C. Steuknkel, M.P. Schalckamp, W. Visser, I.H. Huisveld, M.A. Schalckamp, Immunoreactive renin, prorenin and enzymatically active renin in plasma during pregnancy, and in women taking oral contraceptives. J. Clin. Endocrinol. Metabol. 63, 1008–1015 (1986)

    Article  CAS  Google Scholar 

  19. C.E. Fardella, L. Mosso, C. Gomez-Sanchez, P. Cortes, J. Soto, L. Gómez, M. Pinto, A. Huete, E. Oestreicher, A. Foradori, J. Monterol, Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J. Clin. Endocrinol. Metabol. 85, 1863–1867. (2000)

    Article  CAS  Google Scholar 

  20. G.W. Liddle, Tests of pituitary-adrenal suppressability in the diagnosis of Cushing’s syndrome. J. Clin. Endocrinol. Metabol. 20, 1539–1560 (1960)

    Article  CAS  Google Scholar 

  21. J.A. Hanley, B.I. Mc Neil, The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29–36 (1982)

    PubMed  CAS  Google Scholar 

  22. P. Mulatero, F. Rabbia, A. Milan, C. Paglieri, F. Morello, L. Chiandussi, F. Veglio, Drug effects on Aldosterone/Plasma Renin Activity ratio in primary aldosteronism. Hypertention 40, 897–902 (2002)

    Article  CAS  Google Scholar 

  23. C. Scifarth, S. Trenkel, H. Schobel, E.G. Hahn, J. Hensen, Influence of antihypertensive medication on aldosterone and renin concentration on in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol. 57, 457–465 (2002)

    Article  Google Scholar 

  24. N. Unger, I.L. Schmidt, C. Pitt, M.K. Walz, T. Philipp, K. Mann, S. Petersenn, Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with adrenal mass. Eur. J. Endocrinol. 150, 517–523 (2004), (a) P. Mulatero et al., Trends Endocrinol. Metab. 16,114–119 (2005)

    Google Scholar 

  25. P. Mulatero, M. Stowasser, K.F. Loh, C.E. Fardella, R.D. Gordon, L. Mosso, C.E. Gomez-Sanchez, F. Veglio, W.E. Young, Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J. Clin. Endocrinol. Metabol. 154, 865–873 (2004)

    Google Scholar 

  26. D.A. Calhoun, M.K. Nishizaka, M.A. Zaman, R.B. Thakkar, P. Weissmann, Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40, 892–896 (2002)

    Article  PubMed  CAS  Google Scholar 

  27. W.F. Young Jr Minireview: primary aldosteronism––changing concepts in diagnosis and treatment. Endocrinol. 144, 2208–2213 (2003)

    Article  CAS  Google Scholar 

  28. J.S. Williams, G.H. Williams, A. Raji, X. Jeunemaitre, N.J. Brownv P.N. Hopkins, P.R. Conlin, Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J. Hum. Hypertens. 20, 129–136. (2006)

    Article  PubMed  CAS  Google Scholar 

  29. C. Schirpenbach, L. Seiler, C. Maser-Gluth, F. Rudiger, C. Nickel, F. Beuschlein, Confirmatory testing in normokalaemic primary aldosteronism. Eur. J. Endocrinol. 154, 865–873 (2006)

    Article  PubMed  CAS  Google Scholar 

  30. P. Mulatero, A. Milan, F. Fallo, G. Regolisti, F. Pizzolo, C. Fardella, L. Mosso, L. Marafetti, F. Veglio, M. Maccario, Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J. Clin. Endocrinol. Metabol. 91, 2618–2623. (2006)

    Article  CAS  Google Scholar 

  31. P. Mulatero, R.G. Dluhy, G. Giacchetti, M. Boscaro, F. Veglio, P. Stiewart, Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol. Metab. 16, 114–119 (2005)

    Article  PubMed  CAS  Google Scholar 

  32. M. Terzolo, A. Pia, A. Ali, G. Osella, G. Reimondo, S. Bovio, F. Daffara, M. Procopio, P. Paccotti, G. Borretta, A. Angeli, Adrenal incidentaloma: a new cause of the metabolic syndrome? J. Clin. Endocrinol. Metabol. 87, 998–1003. (2002)

    Article  CAS  Google Scholar 

  33. S. Tsagarakis, D. Vassiliadi, N. Thalassinos, Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J. Endocrinol. Invest. 29, 471–82. (2006)

    PubMed  CAS  Google Scholar 

  34. J. Adachi, Y. Hirai, K. Terui, T. Nakano, Y. Fukuda, T. Suda, H. Sasano, Report of 7 Cases of Adrenal Tumors Secreting Both Cortisol and Aldosterone Internal Medicine, vol. 42. (2003) pp. 714–718

  35. T. Saito, A. Ikoma, T. Saito, H. Tamemoto, Y. Suminaga, S. Yamada, M. Kawakami, T. Suzuki, H. Sasano, S.E. Ishikawa, Possibly simultaneous primary aldosteronism and preclinical Cushing’s syndrome in a patient with double adenomas of right adrenal gland. Endocr. J. 54, 287–93 (2007)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Diabetes Center, Evangelismos Hospital, 45-47, Ipsilantous St., 106-76, Athens, Greece

    M. Tzanela, G. Effremidis, D. Vassiliadi, A. Szabo, N. Gavalas, A. Valatsou, E. Botoula & N. C. Thalassinos

Authors
  1. M. Tzanela
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Effremidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Vassiliadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Szabo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Gavalas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Valatsou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Botoula
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. N. C. Thalassinos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Tzanela.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tzanela, M., Effremidis, G., Vassiliadi, D. et al. The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses. Endocr 32, 136–142 (2007). https://doi.org/10.1007/s12020-007-9028-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-007-9028-8

Keywords

Search

Navigation